Category : Clinical Research, Pharma & Healthcare Financing

Clinical Research, Pharma & Healthcare Financing

Ark Biopharma Gets China Approval for Aizhida to Treat ADHD

PR Newswire
by PR Newswire046
Shanghai Ark Biopharmaceutical Co., Ltd. (“ArkBio”) today announced that China’s National Medical Products Administration (NMPA) has approved the New Drug Application for Serdexmethylphenidate Chloride and...
Clinical Research, Pharma & Healthcare Financing

Ionis & GSK Report Positive Phase 3 Results for Bepirovirsen

Business Wire
by Business Wire061
– Primary endpoint met in both trials –– Bepirovirsen demonstrated a statistically significant and clinically meaningful functional cure rate –– Chronic hepatitis B (CHB) accounts for ~56% of...
Clinical Research, Pharma & Healthcare Financing

Daiichi Sankyo, GENESIS Pharma Agree on VANFLYTA® in CEE

Business Wire
by Business Wire037
Daiichi Sankyo (TSE: 4568) and GENESIS Pharma have entered into an exclusive license and supply agreement for the distribution and commercialization of VANFLYTA® (quizartinib) in 13...
Clinical Research, Pharma & Healthcare Financing

Intelligent Bio Solutions Expands Manufacturing With New Partner

GlobeNewswire
by GlobeNewswire053
Partnership with Syrma Johari Medtech, a globally recognized medical device engineering and manufacturing organization, expands INBS’ global manufacturing capacity, strengthens supply-chain resilience, and supports an...
Clinical Research, Pharma & Healthcare Financing

Mesoblast Announces Changes to Board of Directors’ Leadership Roles

GlobeNewswire
by GlobeNewswire058
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that as foreshadowed at the recent Annual General Meeting the...
Clinical Research, Pharma & Healthcare Financing

Baker Health Launches MELT

PR Newswire
by PR Newswire063
Physician-Led Program Combines Prescription Therapy and Holistic Compounds to Support Sustainable Weight Loss Baker Health, a leading concierge primary care and wellness practice, today announced...
Clinical Research, Pharma & Healthcare Financing

Tri-City Cardiology Announces Care Team Growth

PR Newswire
by PR Newswire071
Pheonix-Based Cardiology Group Continues to Expand Access to Care Across Valley Tri-City Cardiology, a Phoenix-based cardiology group among the largest and most respected in the...
Clinical Research, Pharma & Healthcare Financing

Americans Face Health Insurance Rate Hikes

PR Newswire
by PR Newswire076
Millions of Americans are facing sticker shock when they look to enroll in their ACA health insurance plan for 2026. An analysis by KFF found that the average...
Clinical Research, Pharma & Healthcare Financing

Hope Biosciences Reports Promising Phase II Parkinson’s Trial

Business Wire
by Business Wire059
Houston-area clinical research organization Hope Biosciences Research Foundation (HBRF) today shares positive top-line results of a Phase II clinical trial to evaluate Hope Biosciences’ allogeneic adipose‑derived mesenchymal...
Clinical Research, Pharma & Healthcare Financing

Celltrion Gets Positive CHMP Opinion for SteQeyma™ Autoinjector

Business Wire
by Business Wire061
Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion...
Clinical Research, Pharma & Healthcare Financing

Mondego Bio Selects PTPN2 Inhibitor, Targets First Trials in 2026

PR Newswire
by PR Newswire050
Mondego Bio, a clinical-stage biotechnology company developing next-generation small-molecule immuno-oncology therapies, today announced the formal selection of its lead clinical candidate, ZE00-0388, a highly selective...
Clinical Research, Pharma & Healthcare Financing

Menarini announces CELLSEARCH® CTC biomarker analysis results

PR Newswire
by PR Newswire050
The secondary analysis of the PACE trial highlights the value of counting Circulating Tumor Cells (CTCs) in the blood to help guide treatment escalation or...
Clinical Research, Pharma & Healthcare Financing

Syremis Therapeutics Raises $165M for Mental Health Drugs

Business Wire
by Business Wire085
Addressing major unmet needs in mental health with pharmacology rooted in emerging and clinically validated neuropsychiatric biology Lead program ST-905, a potent M1/M4 muscarinic agonist,...
Clinical Research, Pharma & Healthcare Financing

PharmAla Biotech Contracts UK CDMO for ALA-002 Production

GlobeNewswire
by GlobeNewswire068
PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class...
Clinical Research, Pharma & Healthcare Financing

Orum Therapeutics Raises $100M for Antibody Programs

Business Wire
by Business Wire046
Funding supports advancing therapeutic programs toward clinical development, expanding discovery across novel payload classes to accelerate next-generation degrader-antibody conjugate (DAC) programs and broadening Orum’s global...